DB02152 | K-252a | experimental | unknown | | Details |
DB12742 | Amuvatinib | investigational | unknown | | Details |
DB12200 | Tivantinib | investigational | unknown | | Details |
DB06314 | SGX-523 | investigational | unknown | | Details |
DB06896 | 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide | experimental | unknown | | Details |
DB06995 | N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide | experimental | unknown | | Details |
DB06997 | 2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide | experimental | unknown | | Details |
DB07369 | N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide | experimental | unknown | | Details |
DB07969 | 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol | experimental | unknown | | Details |
DB08791 | 1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE | experimental | unknown | | Details |
DB08875 | Cabozantinib | approved, investigational | yes | antagonist | Details |
DB08865 | Crizotinib | approved, investigational | yes | inhibitor | Details |
DB12267 | Brigatinib | approved, investigational | unknown | inhibitor | Details |
DB12010 | Fostamatinib | approved, investigational | unknown | inhibitor | Details |
DB08079 | AMG-208 | investigational | unknown | inhibitor | Details |
DB11791 | Capmatinib | approved, investigational | yes | inhibitor | Details |
DB15133 | Tepotinib | approved, investigational | yes | inhibitor | Details |
DB11800 | Tivozanib | approved, investigational | unknown | inhibitor | Details |
DB16695 | Amivantamab | approved, investigational | yes | antagonistantibody | Details |
DB01268 | Sunitinib | approved, investigational | unknown | inhibitor | Details |